BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 12208721)

  • 21. Ocular Manifestations of Leukemia and Results of Treatment with Intravitreal Methotrexate.
    Vishnevskia-Dai V; Sella King S; Lekach R; Fabian ID; Zloto O
    Sci Rep; 2020 Feb; 10(1):1994. PubMed ID: 32029770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of primary intraocular lymphoma: fine needle aspiration diagnosis and intravitreal methotrexate treatment.
    Zhao T; Li Y; Tang L; Wei X; Zhu X
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):142-144. PubMed ID: 21336740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of primary intraocular lymphoma treated by intravitreal methotrexate.
    Kim E; Kim C; Lee J; Cho Y
    Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.
    Kim RY; Park JH; Kim M; Park YG; Cho SG; Park YH
    PLoS One; 2021; 16(11):e0260469. PubMed ID: 34813633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of intraocular involvement in the management of primary central nervous system lymphomas.
    Ferreri AJ; Blay JY; Reni M; Pasini F; Gubkin A; Tirelli U; Calderoni A; Zucca E; Cortelazzo S; Chassagne C; Tinguely M; Borisch B; Berger F; Ponzoni M; Cavalli F;
    Ann Oncol; 2002 Apr; 13(4):531-8. PubMed ID: 12056702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
    Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
    Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.
    Chaput F; Amer R; Baglivo E; Touitou V; Kozyreff A; Bron D; Bodaghi B; LeHoang P; Bergstrom C; Grossniklaus HE; Chan CC; Pe'er J; Caspers LE
    Ocul Immunol Inflamm; 2017 Oct; 25(5):639-648. PubMed ID: 27002464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual presentation of cornea verticillata with intravitreal methotrexate in a case of primary intraocular lymphoma.
    Hasan N; Narde HK; Das AK; Chawla R
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35027386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
    Mason JO; Fischer DH
    Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
    Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma.
    Akiyama H; Takase H; Kubo F; Miki T; Yamamoto M; Tomita M; Mochizuki M; Miura O; Arai A
    Cancer Sci; 2016 Oct; 107(10):1458-1464. PubMed ID: 27412324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
    Nguyen DT; Houillier C; Choquet S; Cassoux N; Soussain C; Le Cossec C; Legarf-Tavernier M; Costopoulos M; LeHoang P; Bodaghi B; Omuro A; Hoang-Xuan K; Touitou V
    Ophthalmology; 2016 Sep; 123(9):2047-50. PubMed ID: 27137876
    [No Abstract]   [Full Text] [Related]  

  • 33. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
    Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
    Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
    Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
    Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
    Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
    Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
    Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
    J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement.
    Nakauchi Y; Takase H; Sugita S; Mochizuki M; Shibata S; Ishiwata Y; Shibuya Y; Yasuhara M; Miura O; Arai A
    Int J Hematol; 2010 Jul; 92(1):179-85. PubMed ID: 20464643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
    Shah AC; Kelly DR; Nabors LB; Oakes WJ; Hilliard LM; Reddy AT
    Pediatr Blood Cancer; 2010 Dec; 55(6):1227-30. PubMed ID: 20882580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.